One cheap 50 mg tablet still owns the next twenty-four hours

One cheap 50 mg citrate swallow still owns the calendar day

One cheap 50 mg citrate tablet owns the next twenty-four hours. The US label is one PRN swallow, not a second tablet because dinner delayed the first. Fasted peak sits near one hour. The card files that maximum. It does not ship citrate.

What a licensed 50 mg coupon still cannot buy twice

A coupon for AB-rated 50 mg citrate is a licensed fill after a prescription. Brand Viagra cash sits higher. The 24-hour maximum stays on the generic. So does the nitrate stop. Published bands live below. This desk does not run a cart.

Licensed 50 mg cash this month at four counters

CVS, Publix, Sam's Club, and Harris Teeter already post coupon or warehouse numbers. Figures below are August 2026 snapshots. Your ZIP moves the dollar. Confirm at the counter.

Why Clinicians Still Reach for Sildenafil

Erectile dysfunction affects an estimated 30 million men in the United States. Oral PDE5 inhibitors changed management from injection-only or psychosexual therapy alone to a pharmacologic first step after lifestyle and comorbidity workup.

Twenty-five years after FDA approval, sildenafil remains the cheapest widely available PDE5 inhibitor in most formularies once generic citrate tablets entered the market around 2012. That alone keeps it on the first-line list for men without contraindications, even when patients arrive asking for 'the long one' they saw advertised.

The drug does not fix endothelial disease, hypogonadism, or relationship conflict. It buys a window where cavernosal smooth muscle can stay relaxed if stimulation triggers local nitric oxide. Men with severe autonomic neuropathy or post-prostatectomy nerve injury may still fail - but many get a usable response at 100 mg after a fair trial.

Revatio (sildenafil 20 mg three times daily) shares the same active moiety for pulmonary arterial hypertension. Pharmacy mix-ups between Revatio and Viagra have caused serious overdoses. Any prescription check should confirm indication and tablet strength before the bag leaves the counter.

Cardiovascular screening before the first dose is still good practice: sexual activity stresses the heart similarly to moderate exertion. Stable angina on nitrates is an absolute stop; stable angina on beta-blockers without nitrates is a different conversation guided by cardiology clearance.

Teaching hospitals use sildenafil as the reference PDE5 molecule because its trial archive is the deepest and its food interaction is the most dramatic in the class. When a resident understands sildenafil PK, tadalafil and vardenafil comparisons become intuitive rather than memorized trade names.

Insurance step-therapy often mandates sildenafil before branded long-acting agents. Document IIEF or patient-reported outcomes after an adequate sildenafil trial if prior authorization for tadalafil requires it - eight attempts at optimized dose is a reasonable documentation standard aligned with urology society guidance.

Counterfeit sildenafil from unregulated online sources remains a public health problem: tablet potency varies from zero to supratherapeutic, and adulterants appear in DEA and FDA warning letters. Legitimate generic AB-rated tablets from licensed pharmacies are the safe economic default.

Men with mild LUTS on alpha-blockers can use sildenafil when blood pressure is stable, but the first co-dose week deserves orthostatic vitals. The interaction is pharmacodynamic, not mysterious - two vasodilators in the same afternoon.

Hypogonadal men with symptomatic low testosterone and ED often improve after restoration of testosterone; sildenafil can be co-prescribed when libido returns but vascular ED persists. Treating testosterone solely to fix sildenafil nonresponse without biochemical deficiency wastes time and carries treatment risks.

Pelvic radiation for prostate or rectal cancer damages microvasculature and nerves with delayed ED onset - sildenafil trials included some post-radiation men with lower response rates than surgery-only cohorts. Set expectations before prescribing the first tablet.

Pulmonary hypertension prescribers using Revatio must educate patients never to borrow Viagra from friends for ED - the reverse error also occurs when PAH patients self-escalate without clinic contact.

NO-cGMP-PDE5: Amplification, Not Ignition

Understanding sildenafil as a signal extender rather than an erection switch prevents unrealistic expectations and reduces spurious 'nonresponder' labels after one misfired attempt.

Penile erection requires arterial inflow and venous trapping in the corpora cavernosa. Sexual stimulation activates neuronal and endothelial nitric oxide synthase, raising nitric oxide locally. NO activates soluble guanylate cyclase, which converts GTP to cyclic GMP.

Card note: PDE5 is the dominant phosphodiesterase in corpus cavernosum tissue. It hydrolyzes cGMP back to inactive 5′-GMP, ending the signal. Sildenafil binds the PDE5 catalytic site with high affinity - Ki near 4 nM in biochemical assays - slowing that hydrolysis.

Card note: critical point for every patient conversation: sildenafil amplifies an existing NO signal. No stimulation, no meaningful cGMP rise, no erection. This is why the drug fails in men who skip foreplay or expect a timed erection without partner engagement.

Selectivity matters at the bedside through side effects. PDE6 in retinal photoreceptors is inhibited at higher sildenafil exposures, producing blue-tinted vision or light sensitivity in some men. PDE11 cross-reactivity exists in vitro but is rarely clinically prominent at ED doses.

Downstream, elevated cGMP activates protein kinase G, lowering intracellular calcium in smooth muscle. Arterioles dilate; trabecular spaces expand; the veno-occlusive mechanism engages. Systemic blood pressure falls modestly - roughly single-digit mmHg in normotensive volunteers - which becomes dangerous only when stacked with other vasodilators.

Riociguat stimulates guanylate cyclase directly while sildenafil blocks degradation. Combined use is contraindicated because cGMP rises from both synthesis and reduced clearance - the same logic as the nitrate ban, with a different upstream trigger.

In vitro selectivity ratios versus other PDE isoforms explain the side-effect fingerprint: roughly 10-fold selectivity over PDE6 versus PDE5 at therapeutic concentrations, weaker margins over PDE1 and PDE11. You rarely test these numbers at bedside, but they predict why blue vision is sildenafil-flavored and back pain is tadalafil-flavored within the class.

Cavernous nerve injury from pelvic surgery lowers neuronal NO contribution; endothelial dysfunction lowers eNOS output. Sildenafil cannot bypass absent upstream signal - it only prolongs whatever cGMP was synthesized. That is the mechanistic basis for lower success after radical prostatectomy.

Card note: intracavernosal alprostadil bypasses the NO requirement by directly relaxing smooth muscle via prostaglandin pathways. Combination strategies in refractory cases pair oral PDE5 inhibitors with injection or vacuum devices - different layers of the same hemodynamic goal.

Phosphorylation targets downstream of PKG include Rho kinase pathways that regulate calcium sensitivity; PDE5 inhibition indirectly shifts that balance toward relaxation. You will not exam on Rho kinase, but residents who ask 'why not just inject cGMP?' get the answer: oral PDE5 blockade is the pharmacologically practical lever.

Sildenafil has negligible direct ion channel activity at therapeutic concentrations - the QT concern that dominates vardenafil labeling is less prominent here, though class-wide arrhythmia warnings in unstable CAD still apply to sexual activity itself.

Absorption, Metabolism, and the Food Effect

Oral sildenafil citrate is absorbed rapidly on an empty stomach. Median time to maximum plasma concentration (Tmax) is about 60 minutes in fasting adults, with a range from 30 to 120 minutes depending on gastric emptying and individual CYP3A4 activity.

Absolute bioavailability averages roughly 41% because first-pass metabolism in the gut wall and liver consumes more than half the dose before it reaches systemic circulation. That is why strong CYP3A4 inhibitors can multiply exposure - the presystemic barrier collapses.

Card note: a high-fat meal (≥57% of calories from fat) delays Tmax by about 60 minutes and reduces Cmax by approximately 18%; AUC falls roughly 29%. Label language allows dosing 30 minutes to 4 hours before activity, but a heavy restaurant meal pushes many men past their planned window.

Protein binding exceeds 96%, primarily to albumin and alpha-1-acid glycoprotein. Volume of distribution is about 105 L. Hemodialysis does not meaningfully remove drug; severe renal impairment still demands dose reduction because clearance pathways shift.

The major circulating metabolite, N-desmethylsildenafil, retains about half the parent PDE5 inhibitory potency. When ketoconazole or ritonavir blocks CYP3A4, both parent and metabolite accumulate - clinical duration can outlast the nominal 3-5 hour half-life on paper.

Terminal elimination half-life in healthy volunteers is 3-5 hours. Steady-state concepts apply to Revatio three-times-daily PAH regimens (~5 days to steady state), not to as-needed ED dosing where each dose stands alone.

Age 65 and older increases AUC by about 84% at the same milligram dose - not because absorption improves but because hepatic clearance falls. The label's 25 mg recommendation in elderly men is PK-driven, not ageist caution.

CYP2C9 contributes a minor metabolic route; fluvoxamine and other dual-pathway inhibitors are less studied than pure CYP3A4 blockers but still warrant conservative dosing when polypharmacy is complex.

Card note: population pharmacokinetic models in FDA reviews identified weight and creatinine clearance as secondary covariates. Therapeutic drug monitoring is not used clinically - dose titration by effect and side effects remains the algorithm.

Card note: intravenous sildenafil exists in research and PAH inpatient settings but is not part of outpatient ED care. Oral tablet PK drives every counseling point about onset and food.

Smoking induces CYP1A2 minimally and CYP3A4 modestly - heavy smokers may notice slightly shorter effect windows, though quitting produces bigger ED improvement through vascular recovery than any PK shift.

Registration Trials and IIEF Endpoints

Card note: FDA approval rested on IIEF and patient diary endpoints in thousands of men - endpoints still used in urology research today.

Pivotal trials were randomized, double-blind, placebo-controlled, parallel-group studies in men with documented erectile dysfunction of mixed etiology. Goldstein and colleagues published the landmark 24-week results in the New England Journal of Medicine in 1998.

Men took fixed doses of 25, 50, or 100 mg or placebo about one hour before attempted intercourse. All active arms beat placebo on the International Index of Erectile Function erectile function domain and on diary-documented successful penetration and intercourse.

Dose response was clear: 100 mg produced the largest IIEF gains and the highest successful intercourse rates - often above 70% in mild-to-moderate organic ED - but also the most headache and flushing. Most clinicians start at 50 mg and move up or down based on one or two real-world attempts.

Organic vasculogenic ED responds well; post-radical prostatectomy neurovascular injury attenuates response because the NO substrate is reduced. Diabetes sits in the middle - still better than placebo in subgroup analyses, but absolute success rates trail nondiabetic cohorts.

Onset in practice mirrors PK: 30-60 minutes fasted is typical; duration of usable erectogenic effect aligns with half-life and active metabolite, often quoted as up to 4-5 hours. That window is shorter than tadalafil but sufficient for many couples who plan around a single encounter.

Open-label extensions out to two or three years showed sustained benefit in responders without pharmacologic tachyphylaxis. Apparent loss of effect usually tracks worsening diabetes, new beta-blocker therapy, or depression - not PDE5 downregulation.

Card note: meta-analyses across PDE5 inhibitors at equipotent exposures show overlapping odds ratios for successful intercourse. Agent choice is therefore less about raw efficacy and more about duration preference, food independence, and side-effect timing - sildenafil's Achilles heel is the fatty meal, not the IIEF score.

Secondary endpoints in registration trials included intercourse satisfaction, orgasmic function, and overall treatment satisfaction - all favored active drug over placebo at 50 and 100 mg. The minimal clinically important difference on IIEF-EF has been debated around 4-5 points; typical trial means exceeded that threshold at effective doses.

Men on SSRIs for depression show blunted erectile response; sildenafil trials included SSRI-associated ED subsets with retained superiority over placebo, though dose escalation to 100 mg was more frequently required.

Spinal cord injury patients with preserved reflexogenic erections sometimes respond when psychogenic pathways remain intact; rehabilitation medicine protocols address autonomic dysreflexia risk separately from PDE5 dosing.

Successful intercourse endpoint definitions in FDA statistical reviews required penetration and completion - partial rigidity without penetration counted as failure, which is stricter than casual patient language about 'getting hard.'

Placebo response in ED trials runs 20-30% for diary endpoints because psychogenic components and regression to the mean matter; active drug separation must exceed that background, and sildenafil did so consistently at 50 and 100 mg.

Avanafil and newer agents entered the market with non-inferiority designs versus sildenafil rather than superiority claims - regulatory acceptance that the class ceiling was already defined by 1998 data.

PRN Ladder, Titration, and Meal Timing

Standard starting dose for erectile dysfunction is 50 mg orally as needed once per day maximum. Increase to 100 mg if tolerated and insufficient; decrease to 25 mg if headache, flushing, or hypotension dominate.

Card note: label-directed special populations start at 25 mg: age 65 and older, mild-to-moderate hepatic impairment (Child-Pugh class B), creatinine clearance below 30 mL/min, and co-administration with potent CYP3A4 inhibitors.

Child-Pugh class C hepatic impairment lacks robust ED dose-finding data; labeling recommends against routine ED use because exposure is unpredictable and hypotension risk rises without reliable benefit.

Timing flexibility is official: 30 minutes to 4 hours before sexual activity. In practice, tell fasted patients to think 'about an hour'; tell steak-house patients to think 'two hours or skip the ribeye.'

Daily sildenafil for ED is off-label. Some research protocols explored endothelial biomarkers with daily low dose, but standard care remains PRN. Doubling up after a failed attempt same day is unsafe and ineffective.

Never interchange Revatio 20 mg TID with Viagra 50-100 mg PRN. A man who swallows a 100 mg Viagra tablet thinking it is his 'pulmonary dose' receives five times the PAH unit dose in one swallow.

Splitting 100 mg tablets to save cost is common patient behavior; counsel that scored generics allow halving for 50 mg trials but quartering 25 mg pieces is imprecise and not label-endorsed.

Alcohol in moderation is not contraindicated, but intoxication impairs erectile performance independent of sildenafil and worsens orthostatic dizziness when combined.

Storage at controlled room temperature protects citrate salt stability; bathroom humidity degrades tablets over months - a practical detail for men who keep pills in medicine cabinets above the shower.

Maximum recommended dosing frequency once per 24 hours applies even when 100 mg produces partial response - two 50 mg tablets same day is not label-concordant and increases headache without additive rigidity benefit in trial rechallenge data.

Pediatric accidental ingestion of single adult tablet rarely causes prolonged priapism in prepubertal children but warrants poison control call - different from therapeutic use in adolescent PAH under specialist care.

Nitrates, CYP3A4, and Alpha Blockers

Interaction screening is non-negotiable because the dangerous pairs (nitrates, strong CYP3A4 inhibitors, riociguat) are pharmacologically predictable from the mechanism.

Organic nitrates - nitroglycerin SL, isosorbide mononitrate, isosorbide dinitrate - are contraindicated. PDE5 inhibition prevents cGMP breakdown while nitrates drive cGMP synthesis via NO. The result can be profound hypotension, syncope, myocardial ischemia, and death.

Card note: recreational nitrites ('poppers') obey the same pharmacology with faster, less predictable kinetics. Ask directly during intake; men rarely volunteer this.

Potent CYP3A4 inhibitors raise sildenafil AUC dramatically. Ritonavir boosted regimens increased sildenafil AUC about 11-fold in interaction studies; maximum recommended ED dose with ritonavir is 25 mg no more than every 48 hours per label. Ketoconazole and itraconazole also require the 25 mg cap.

Moderate inhibitors - erythromycin, cimetidine - warrant dose reduction and side-effect counseling. Inducers such as rifampin and carbamazepine may shorten the effective window by accelerating clearance.

Alpha-1 blockers for BPH or hypertension (doxazosin, tamsulosin, terazosin) add orthostatic hypotension risk. Initiate sildenafil only after alpha-blocker dose is stable; start sildenafil at 25 mg when combining.

Riociguat is contraindicated. Moderate alcohol may worsen vasodilation and orthostatic symptoms; heavy drinking impairs performance independent of drug PK.

Card note: hIV protease inhibitors beyond ritonavir vary in CYP3A4 inhibition potency - check each new antiretroviral against the sildenafil interaction table when treating men in HIV clinic.

Immunosuppressants tacrolimus and cyclosporine are CYP3A4 substrates with bidirectional interaction potential; transplant recipients needing sildenafil deserve pharmacist-led review of both drug levels and ED dose.

St. John's wort induction may shorten the effective window enough that men report sudden treatment failure after starting an herbal depression remedy - ask about supplements at every visit.

Isosorbide mononitrate for angina prophylaxis is contraindicated regardless of dosing schedule - the sustained NO donor effect overlaps with sildenafil for the entire nitrate dosing interval, not just the hour after a sublingual nitroglycerin tablet.

Doxazosin 4 mg daily plus sildenafil 50 mg produced greater standing blood pressure reductions than either alone in interaction studies; tamsulosin 0.4 mg was somewhat better tolerated but still warrants 25 mg sildenafil start when combining.

Headache, Vision, Priapism, and Class Warnings

Headache, flushing, dyspepsia, nasal congestion, and dizziness head the phase III list. They correlate with peak plasma concentration and usually self-resolve within a few hours. Headache incidence rises from roughly 16% at 50 mg toward 28% at 100 mg in pooled data.

Visual changes - blue hue, increased light sensitivity, blurred vision - link to PDE6 inhibition in retina. They are typically transient. Sudden unilateral vision loss (possible non-arteritic anterior ischemic optic neuropathy) is rare but mandates immediate stop and urgent ophthalmology evaluation.

Card note: sudden hearing decrease or tinnitus appears in post-marketing reports across PDE5 inhibitors as a class signal. Document onset timing; discontinue and refer to ENT for audiometry when symptoms are acute.

Priapism (painful erection beyond 4 hours) is uncommon - under 0.1% in trials - but urologic emergency. Sickle cell disease, multiple myeloma, and leukemia carry higher risk. Treat with aspiration, intracavernosal phenylephrine, and surgery if refractory.

Serious cardiovascular events in ED trials matched placebo among men cleared for sexual activity. Do not prescribe when sexual activity itself is contraindicated - severe unstable heart failure, recent stroke, uncontrolled hypertension.

Cutaneous serious reactions including Stevens-Johnson syndrome appear in FAERS. Stop the drug for progressive rash with mucosal involvement.

Facial flushing often peaks with Cmax and habituates in some men after three to five doses without dose change - distinguish tolerance from tachyphylaxis.

Dyspepsia may reflect lower esophageal sphincter relaxation; taking sildenafil with a small non-fatty snack sometimes helps men who get heartburn on empty stomach.

Card note: syncope reports usually involve nitrates, alpha-blockers, or dehydration - reconstruct the timeline before blaming the PDE5 inhibitor alone.

Phase III pooled analysis reported dyspepsia in roughly 13% at 50 mg and 17% at 100 mg - antacids do not prevent mechanism-based reflux symptoms; dose reduction often works better.

Non-arteritic anterior ischemic optic neuropathy post-marketing incidence remains debated; FDA added class warning without proving agent-specific causality - document visual acuity baseline if patient has crowded disc.

Elderly, Hepatic, Renal, and Diabetic Men

Healthy elderly men aged 65 and older show about 84% higher plasma AUC at the same dose compared with younger volunteers because clearance falls. Starting at 25 mg reduces orthostatic symptoms while preserving efficacy in many.

Child-Pugh class B: begin 25 mg. Class C: avoid routine ED dosing unless specialist accepts risk with close monitoring - label does not support standard use.

Creatinine clearance below 30 mL/min doubles AUC; 25 mg starting dose is mandated. Dialysis does not remove drug meaningfully; no supplemental dose after sessions for PRN use.

Diabetes mellitus is the most common comorbidity in ED clinics. Sildenafil remains statistically superior to placebo in diabetic subgroups, but nerve and microvascular damage lower absolute success rates. Optimize A1c, blood pressure, and lipids alongside the pill.

Card note: post-prostatectomy patients use sildenafil in penile rehabilitation protocols to encourage nocturnal and induced perfusion during neuropraxia recovery. Expect lower rigidity scores than in pure vasculogenic ED; combination with devices or intracavernosal alprostadil is common in refractory cases.

Retinitis pigmentosa involves PDE6 pathway mutations; labeling lists relative contraindication. Shared decision-making with ophthalmology is reasonable when vision is already compromised.

Heart failure with preserved ejection fraction and borderline hypotension: start 25 mg and measure seated BP before and two hours after first dose in clinic when feasible.

Kidney transplant recipients on sirolimus or everolimus need mTOR and CYP3A4 review; sildenafil is not contraindicated but exposure shifts warrant low starting dose.

Obesity correlates with ED severity and may alter drug distribution; efficacy trials included wide BMI ranges with dose titration still effective at 100 mg in many obese men.

Sickle cell trait without full disease still carries priapism risk though lower than HbSS - counsel all men with hemoglobinopathy before first prescription regardless of agent.

Chronic kidney disease stage 4-5 without dialysis: 25 mg start applies; men on nocturnal home dialysis have same protein binding considerations as in-center hemodialysis.

Ward Tips and Questions Patients Actually Ask

Most 'failures' in primary care are adherence, timing, or expectation problems - not pharmacologic nonresponse.

'Will it work if I don't feel in the mood?' - No. Explain arousal dependence twice; write it on the after-visit summary once.

'Can I take it after dinner?' - Yes, but a heavy fatty meal delays onset up to two hours. Light meal or empty stomach if they want the 60-minute plan.

'What if nothing happens?' - Retry at least four to eight separate occasions at optimized dose before calling it failure. One try after too much alcohol does not count.

Emergency card: chest pain after sildenafil - do not let EMS or the ED team give nitroglycerin until they know a PDE5 inhibitor was taken within 24 hours. Patients should carry that fact in wallet medication lists.

Generic blue tablets are bioequivalent under fasting conditions; shape change alone causes nocebo failures. Mention the manufacturer switch proactively.

Partners hear 'Viagra' and assume hours of erection. Clarify that the drug permits erection with stimulation; it does not trap blood indefinitely. Priapism instructions belong in the same conversation.

'Is generic as good?' - Yes for AB-rated generics under fasting bioequivalence rules; same active ingredient, same food counseling.

Card note: 'Can my wife take it?' - Off-label female studies exist; not FDA approved for women. Do not share prescription.

Document last dose time in the chart when admitting for chest pain - ED medications are easy to omit on medication lists.

Young men with performance anxiety sometimes succeed with sildenafil plus brief cognitive behavioral therapy; the pill alone does not fix spectatoring or relationship conflict - refer when history suggests primary psychogenic ED.

Veterans Affairs and public systems often default to sildenafil first on formulary; knowing PAH Revatio interaction prevents dual-product errors in systems with both on the same wholesale contract.

Card note: goldstein 1998 NEJM primary outcome combined psychogenic and organic ED - subgroup analyses later showed organic responders had slightly lower placebo-corrected benefit but still significant at 100 mg.

Three multinational phase III trials totaling over 4,500 randomized men underpinned FDA approval - scale comparable to modern cardiovascular outcomes trials though endpoints were patient-reported function not MACE.

Bottom Line for Prescribers

Card note: sildenafil remains a first-line PDE5 inhibitor with the deepest generic pricing and the most familiar name among patients. Efficacy in registration trials was dose-dependent on IIEF and intercourse success endpoints.

Mechanism requires sexual stimulation; the drug extends cGMP, it does not create erections de novo. Food - especially high-fat meals - delays absorption in a clinically obvious way unique within the class at this magnitude.

Contraindications are absolute for nitrates, nitrites, and riociguat. Strong CYP3A4 inhibitors cap the dose at 25 mg. Alpha-blocker combinations need stable baseline dosing and cautious titration.

Start 50 mg PRN for most men; 25 mg for elderly, hepatic, renal, or interacting regimens; maximum 100 mg once daily. Duration of action roughly 4-5 hours - plan accordingly.

Side effects are vasodilatory and dose-related: headache, flushing, dyspepsia, visual symptoms. Priapism, sudden vision loss, and sudden hearing loss require urgent action though they are rare.

When sildenafil fails after adequate trials, switch agents or add second-line options - do not assume class failure until another PDE5 inhibitor is tested under appropriate conditions.

Revatio and Viagra product confusion remains a medication safety priority - separate inventory bins in pharmacy and explicit indication documentation in e-prescribing.

Generic pricing makes sildenafil the cost-effective anchor; duration-limited window is acceptable when couples plan timing and avoid high-fat pre-coital meals.

Card note: the 1998 label established the template every subsequent PDE5 inhibitor followed: IIEF-EF domain change, percentage of successful intercourse attempts per patient diary, and safety monitoring for hypotension, vision, and priapism. Knowing that history helps you read tadalafil and vardenafil labels faster because the skeleton repeats.

When a man asks whether sildenafil 'still works' compared with newer agents, the honest answer from trial math is yes for most mild-to-moderate ED - differences show up in planning convenience and side-effect flavor, not a magic category jump in rigidity for the average patient.

Sildenafil citrate salt dissociates in gastric acid; film coating protects from light and moisture. Chewing or crushing tablets bypasses coating without improving absorption enough to matter - swallow whole with water.

Card note: international labels harmonize on nitrate contraindication but differ on alpha-blocker co-administration language; U.S. prescribing information remains the reference for American patients and Step-therapy documentation.

Ritonavir 600 mg twice daily with sildenafil 25 mg single dose produced Cmax and AUC increases consistent with near-complete loss of presystemic extraction - HIV clinic workflows should stock 25 mg sildenafil or avoid co-prescription entirely when ED treatment is elective.

Successful intercourse rates at 100 mg in pooled phase III analyses approached 80% in mild ED and 60% in moderate ED cohorts using strict diary definitions - numbers decline meaningfully when patients only remember 'sometimes works' without structured attempts.

Women of childbearing age partners need no special precaution - sildenafil is not teratogenic in standard use; pregnancy risk is partner's usual baseline, not drug exposure through semen at labeled doses.

N-desmethylsildenafil AUC increases disproportionately when CYP3A4 blocked - effective functional half-life extends beyond parent 3-5 hours when patient takes clarithromycin for COPD exacerbation.

Exercise treadmill testing at 5-6 METs without angina remains practical standard before first PDE5 prescription in men with CAD risk factors - sildenafil does not substitute for that assessment.

Avanafil and other newer PDE5 agents entered market with non-inferiority designs versus sildenafil - when teaching drug development, sildenafil remains the 1998 efficacy benchmark for class.

Priapism risk with sickle cell trait is lower than HbSS but nonzero - hematology history belongs in intake before any PDE5 first dose.